The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status

This publication has 34 references indexed in Scilit:

• EGFR,KRAS,BRAFandALKgene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype
  European Respiratory Journal, 2013
• Correlation of EGFR mutation and predominant histologic subtype according to the new lung adenocarcinoma classification in Chinese patients
  Medical Oncology, 2013
• Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose
  Lung Cancer, 2013
• Frequency of Driver Mutations in Lung Adenocarcinoma from Female Never-Smokers Varies with Histologic Subtypes and Age at Diagnosis
  Clinical Cancer Research, 2012
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
  New England Journal of Medicine, 2011
• TNM seventh edition: What's new, what's changed
  Cancer, 2010
• Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975
  Annals of Oncology, 2009
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004